APA (7th ed.) Citation

Chen, X., Wang, Y., Dong, Y., Yang, J., Xie, B., & Zhang, D. (2025). Helicobacter pylori Eradication: Why Recurrence Risk Should Not Dictate Treatment Decisions. Therapeutics & Clinical Risk Management, 21, 1855. https://doi.org/10.2147/TCRM.S566086

Chicago Style (17th ed.) Citation

Chen, Xinglan, Yuanyuan Wang, Yeze Dong, Jinxia Yang, Baoyuan Xie, and Dekui Zhang. "Helicobacter Pylori Eradication: Why Recurrence Risk Should Not Dictate Treatment Decisions." Therapeutics & Clinical Risk Management 21 (2025): 1855. https://doi.org/10.2147/TCRM.S566086.

MLA (9th ed.) Citation

Chen, Xinglan, et al. "Helicobacter Pylori Eradication: Why Recurrence Risk Should Not Dictate Treatment Decisions." Therapeutics & Clinical Risk Management, vol. 21, 2025, p. 1855, https://doi.org/10.2147/TCRM.S566086.